Docking and Linking of Fragments To Discover Jumonji Histone Demethylase Inhibitors

Authors:
Publisher website
Google Scholar
Abstract
Development of tool molecules that inhibit Jumonji demethylases allows for the investigation of cancer-associated transcription. While scaffolds such as 2,4-pyridinedicarboxylic acid (2,4-PDCA) are potent inhibitors, they exhibit limited selectivity. To discover new inhibitors for the KDM4 demethylases, enzymes overexpressed in several cancers, we docked a library of 600 000 fragments into the high-resolution structure of KDM4A. Among the most interesting chemotypes were the 5-aminosalicylates, which docked in two distinct but overlapping orientations. Docking poses informed the design of covalently linked fragment compounds, which were further derivatized. This combined approach improved affinity by ∼3 log-orders to yield compound 35 (Ki = 43 nM). Several hybrid inhibitors were selective for KDM4C over the related enzymes FIH, KDM2A, and KDM6B while lacking selectivity against the KDM3 and KDM5 subfamilies. Cocrystal structures corroborated the docking predictions. This study extends the use of structure-based docking from fragment discovery to fragment linking optimization, yielding novel KDM4 inhibitors.
Funding Information
  • Chicago Community Trust
  • Arthritis Research UK
  • National Institute for Health Research
  • University of California, San Francisco
  • Wellcome Trust
  • Rosetrees Trust
  • V Foundation for Cancer Research
  • National Institute of General Medical Sciences (GM59957, GM71630)
  • Structural Genomics Consortium

This publication has 76 references indexed in Scilit: